First Trust NYSE Arca Biotechnology Index Fund (FBT) Short Interest Ratio & Short Volume

Short interest is the volume of First Trust NYSE Arca Biotechnology Index Fund shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 5,600 shares of FBT short. 0.09% of First Trust NYSE Arca Biotechnology Index Fund's shares are currently sold short. Learn More on First Trust NYSE Arca Biotechnology Index Fund's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.09% of First Trust NYSE Arca Biotechnology Index Fund's floating shares are currently sold short.

First Trust NYSE Arca Biotechnology Index Fund saw a increase in short interest during the month of May. As of May 31st, there was short interest totaling 5,600 shares, an increase of 12.0% from the previous total of 5,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.09% of First Trust NYSE Arca Biotechnology Index Fund's shares are currently sold short. Here is how the short interest of companies compare to First Trust NYSE Arca Biotechnology Index Fund: First Trust Health Care AlphaDEX Fund (0.03%), Invesco S&P 500 Equal Weight Health Care ETF (1.19%), iShares U.S. Healthcare Providers ETF (2.33%), VanEck Pharmaceutical ETF (41.19%), iShares U.S. Pharmaceuticals ETF (5.55%), Direxion Daily S&P Biotech Bull 3x Shares (11.63%), VanEck Biotech ETF (0.37%), Invesco Pharmaceuticals ETF (0.34%), Invesco Biotechnology & Genome ETF (0.03%), SPDR S&P Health Care Equipment ETF (0.51%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

Short selling FBT is an investing strategy that aims to generate trading profit from First Trust NYSE Arca Biotechnology Index Fund as its price is falling. FBT shares are trading down $0.75 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for First Trust NYSE Arca Biotechnology Index Fund occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FBT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FBT, twice per month. The most recent reporting period available is May, 31 2025.